1092539-44-0

基本信息
SAR131675外消旋體
VEGFR3抑制劑(SAR131675)
(-)-2-氨基-1-乙基-1,4-二氫-7-(3-羥基-4-甲氧基-3-甲基-1-丁炔-1-基)-N-甲基-4-氧代-1,8-萘啶-3-甲酰胺
(Rac)-SAR131675
SAR131675 Racemate
SAR131675/SAR-131675
(R)-2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1
2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-n-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide
(-)-2-Amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-1,8-naphthyridine-3-carboxamide
1,8-Naphthyridine-3-carboxamide, 2-amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-, (-)-
物理化學(xué)性質(zhì)
制備方法

42841-64-5

1092523-24-4

1092538-80-1
在20 mL甲醇中懸浮3 g(10.69 mmol)2-氨基-7-氯-1-乙基-N-甲基-4-氧代-1,4-二氫[1,8]二氮雜萘-3-甲酰胺,置于80 mL微波管中。向懸浮液中加入DMF/Et3N混合液(V/V; 1/1),隨后用氬氣鼓泡10分鐘。依次加入1.83 g(±)-1-甲氧基-2-甲基-3-丁炔-2-醇(16.03 mmol)、0.081 g CuI(0.43 mmol)和0.375 g雙(三苯基膦)二氯化鈀(II)(0.53 mmol)。將密封管置于微波反應(yīng)器(CEM Discover型號(hào))中,在90℃、100 W功率下加熱60分鐘。反應(yīng)完成后,冷卻混合物并蒸發(fā)至干。將殘余物溶解于乙酸乙酯/THF混合溶劑中,用0.1 N HCl水溶液洗滌。有機(jī)相經(jīng)無(wú)水硫酸鈉干燥,過(guò)濾后真空濃縮。通過(guò)硅膠柱色譜純化殘余物(干法上樣,洗脫梯度:環(huán)己烷/乙酸乙酯,30:70至20:80),得到2.49 g淺黃色固體產(chǎn)物。產(chǎn)物可經(jīng)乙醇重結(jié)晶得白色晶體,熔點(diǎn)為211℃。質(zhì)譜(MH+): 358。產(chǎn)率: 65%。1H NMR(DMSO-d6, 400 MHz, δ ppm): δ 11.75(s, <1H, 寬峰); 11.00(q, 1H, 寬峰); 8.45(d, 1H); 8.00(s, 1H, 寬峰); 7.4(d, 1H); 5.8(s, 1H); 4.4(q, 2H); 3.5-3.3(m + s, 5H); 2.8(d, 3H); 1.45(s, 3H); 1.2(t, 3H)。
參考文獻(xiàn):
[1] Patent: US2010/144757, 2010, A1. Location in patent: Page/Page column 8